Dietary Supplement Risk Prompts Investigation By U.S. Health Regulators
The Associated Press (9/14, Perrone) reports that “Almost a year after studies showed the diet pill Meridia [sibutramine] increases heart attack and stroke risk, US health regulators announced they will consider pulling the Abbott Laboratories’ drug off the market.”
Do you use this dietary supplement? If so data “released in November showed patients with heart disease taking the drug had a more than 11 percent risk of cardiovascular risks compared with 10 percent of those taking a placebo. European regulators have already pulled the product off the market in January.” The FDA “said Monday that it is considering a range of options for the drug, including simply adding more warning labels,” and on Wednesday “an outside panel of experts will weigh in on the course of action FDA should take.”
Talk to your doctor to make sure you aren’t facing a dietary supplement risk from products you’re using. Also, contact your attorney to find out your options. Have a question? Ask Marvin Lundy at Lundylaw.com.